期刊
MOLECULAR THERAPY
卷 17, 期 5, 页码 889-896出版社
CELL PRESS
DOI: 10.1038/mt.2009.30
关键词
-
资金
- National Tsing Hua University Booster Program [97N2511E1]
- VTY Joint Research Program
- Tsou's Foundation [VGHUST97-P5-15]
- National Tsing Hua University-Chang Gung Memorial Hospital Joint Research Program [96N2425E1, CMRPG361041]
- National Science Council [NSC 97-2627-B-007-014, NSC 97-2622-E-007-009-CC3]
- Ministry of Economic Affairs [98EC-17-A-17-R7-0525]
Baculovirus holds great promise for the genetic modification of mesenchymal stem cells (MSCs). However, whether baculovirus transduction provokes undesired MSCs responses that might compromise their in vivo applications has yet to be examined. Hereby, we unraveled that baculovirus transduction of human MSCs upregulated the transcription of interleukin (IL)-1 beta, interferon (IFN)-alpha and IL-6, but not tumor necrosis factor (TNF)-alpha and IFN-gamma. However, only IL-6 secretion was detectable by enzyme-linked immunosorbent assay (ELISA). Baculovirus transduction also stimulated transient, low level upregulation of human leukocyte antigen I (HLA-I) on the human MSCs surface, yet it did not either altered the HLA-II expression or impaired the MSCs ability to inhibit lymphocyte proliferation. After transplantation into allogeneic rats, the transduced rat MSCs elicited transient, mild macrophage responses, but the cells remained tolerant as judged by the persistence of transplanted cells and absence of CD8(+) T cells infiltration. Besides, transplantation of the transduced MSCs did not provoke systemic induction of monocytes and CD8(+) T cells. This study, for the first time, explores the responses of MSCs to virus transduction and confirms the safety of transplanting baculovirus-engineered MSCs into immunocompetent animals for cell-based gene therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据